4月22日,颠覆传统,不容错过!

2016-04-12 MedSci MedSci原创

由梅斯医学开发的 “梅斯医生”即将正式上线,我们将于2016年4月22日在上海世博洲际酒店举办梅斯医生产品发布会。梅斯医生通过模拟了真实的诊疗全流程,通过与虚拟患者的交互问答,让医生在短时间内能接触到大量经典的、接近真实的病例,极大提升医生的临床实践能力。用科技点亮梦想,助力医生成长!“梅斯医生”关键词:http://www.medsci.cn/z/msys/mt.html

由梅斯医学开发的 “梅斯医生”即将正式上线,2016年4月22日将在上海世博洲际酒店举办梅斯医生产品发布会。

梅斯医生通过模拟了真实的诊疗全流程,通过与虚拟患者的交互问答,让医生在短时间内能接触到大量经典的、接近真实的病例,极大提升医生的临床实践能力。

用科技点亮梦想,助力医生成长!



“梅斯医生”关键词:



.增强实景,沉浸式学习,启发临床思维

根据学习者自身的能力进行分阶,定制化的选择内容,向学习者传递特定的诊疗知识和信息。增强实景作为与学习者沟通的平台,使信息传递的过程更加生动,从而脱离传统的单向说教模式,将互动元素引入到沟通环节中,让学习者在轻松、愉快、积极的环境下进行学习。

.精选病例,模拟真实诊疗过程

通过病人提供主诉->病史采集->体格检查->实验室/辅助检查->诊断->治疗原则确定,将患者就诊过程和医师检查及诊断过程虚拟化。事先设定的精选病例,用户在软件中通虚拟人物的交互,进行模拟的病情采集及诊疗过程。

.开放,实时知识更新系统

系统能对产品进行完善、升级,包括增强病史采集环节的交互性,对模拟病人进行一些特异性体征的展现,可允许进行尝试性治疗、观察结果及调整诊断及治疗等等,并不断增加病例数量,提高内容的质量及丰富度。比起传统的训练更为灵活,获取所需支持诊断信息的过程基本开放。

“梅斯医生”体验馆

在发布会现场,专门设置“梅斯医生”体验馆,用一个小小的眼镜,带你“上天入地”,亲身体验科技带来的震感!

4月22日,不见不散,点击链接,直接报名参加发布会:https://www.medsci.cn/z/msys/mt.html

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=78626, encodeId=dfd4e8626e1, content=预祝成功!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Apr 15 21:55:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77953, encodeId=0247e7953c7, content=赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:07:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77952, encodeId=b95ae795270, content=期待进一步, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:06:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77771, encodeId=780ee7771fb, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Apr 14 08:15:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77711, encodeId=71f1e771115, content=工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77710, encodeId=acb6e771087, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:15:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77580, encodeId=1477e7580e9, content=好想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Wed Apr 13 05:43:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77577, encodeId=2dafe757793, content=非常赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Apr 12 23:47:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77574, encodeId=4c3fe75743e, content=如此期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIuqOuvZLWMJ8yAVHKNPBSKWLKHx7ibIhutJv2OfnTK9MQH5jpicpw5EJTmD0M0q2wOG3CZO9wTxa9A/132, createdBy=75561684788, createdName=yilibaisha, createdTime=Tue Apr 12 23:26:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77572, encodeId=0e2de757204, content=期待好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3wX2G6elNRPKfNx9ZncyrF3PLdiaO0ua9zmSwUV0gyyNQhoG3ObEqbruynTicFKTDNAbYdlgjqS6UbT80ricnV8zgO/0, createdBy=47021668212, createdName=hbjxgrp1213, createdTime=Tue Apr 12 23:00:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2016-04-15 lyh994

    预祝成功!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=78626, encodeId=dfd4e8626e1, content=预祝成功!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Apr 15 21:55:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77953, encodeId=0247e7953c7, content=赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:07:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77952, encodeId=b95ae795270, content=期待进一步, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:06:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77771, encodeId=780ee7771fb, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Apr 14 08:15:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77711, encodeId=71f1e771115, content=工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77710, encodeId=acb6e771087, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:15:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77580, encodeId=1477e7580e9, content=好想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Wed Apr 13 05:43:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77577, encodeId=2dafe757793, content=非常赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Apr 12 23:47:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77574, encodeId=4c3fe75743e, content=如此期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIuqOuvZLWMJ8yAVHKNPBSKWLKHx7ibIhutJv2OfnTK9MQH5jpicpw5EJTmD0M0q2wOG3CZO9wTxa9A/132, createdBy=75561684788, createdName=yilibaisha, createdTime=Tue Apr 12 23:26:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77572, encodeId=0e2de757204, content=期待好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3wX2G6elNRPKfNx9ZncyrF3PLdiaO0ua9zmSwUV0gyyNQhoG3ObEqbruynTicFKTDNAbYdlgjqS6UbT80ricnV8zgO/0, createdBy=47021668212, createdName=hbjxgrp1213, createdTime=Tue Apr 12 23:00:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2016-04-14 李继凯

    赞一个!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=78626, encodeId=dfd4e8626e1, content=预祝成功!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Apr 15 21:55:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77953, encodeId=0247e7953c7, content=赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:07:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77952, encodeId=b95ae795270, content=期待进一步, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:06:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77771, encodeId=780ee7771fb, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Apr 14 08:15:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77711, encodeId=71f1e771115, content=工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77710, encodeId=acb6e771087, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:15:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77580, encodeId=1477e7580e9, content=好想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Wed Apr 13 05:43:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77577, encodeId=2dafe757793, content=非常赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Apr 12 23:47:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77574, encodeId=4c3fe75743e, content=如此期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIuqOuvZLWMJ8yAVHKNPBSKWLKHx7ibIhutJv2OfnTK9MQH5jpicpw5EJTmD0M0q2wOG3CZO9wTxa9A/132, createdBy=75561684788, createdName=yilibaisha, createdTime=Tue Apr 12 23:26:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77572, encodeId=0e2de757204, content=期待好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3wX2G6elNRPKfNx9ZncyrF3PLdiaO0ua9zmSwUV0gyyNQhoG3ObEqbruynTicFKTDNAbYdlgjqS6UbT80ricnV8zgO/0, createdBy=47021668212, createdName=hbjxgrp1213, createdTime=Tue Apr 12 23:00:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2016-04-14 李继凯

    期待进一步

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=78626, encodeId=dfd4e8626e1, content=预祝成功!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Apr 15 21:55:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77953, encodeId=0247e7953c7, content=赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:07:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77952, encodeId=b95ae795270, content=期待进一步, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:06:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77771, encodeId=780ee7771fb, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Apr 14 08:15:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77711, encodeId=71f1e771115, content=工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77710, encodeId=acb6e771087, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:15:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77580, encodeId=1477e7580e9, content=好想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Wed Apr 13 05:43:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77577, encodeId=2dafe757793, content=非常赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Apr 12 23:47:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77574, encodeId=4c3fe75743e, content=如此期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIuqOuvZLWMJ8yAVHKNPBSKWLKHx7ibIhutJv2OfnTK9MQH5jpicpw5EJTmD0M0q2wOG3CZO9wTxa9A/132, createdBy=75561684788, createdName=yilibaisha, createdTime=Tue Apr 12 23:26:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77572, encodeId=0e2de757204, content=期待好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3wX2G6elNRPKfNx9ZncyrF3PLdiaO0ua9zmSwUV0gyyNQhoG3ObEqbruynTicFKTDNAbYdlgjqS6UbT80ricnV8zgO/0, createdBy=47021668212, createdName=hbjxgrp1213, createdTime=Tue Apr 12 23:00:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2016-04-14 1de5ae28m43(暂无匿称)

    期待

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=78626, encodeId=dfd4e8626e1, content=预祝成功!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Apr 15 21:55:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77953, encodeId=0247e7953c7, content=赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:07:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77952, encodeId=b95ae795270, content=期待进一步, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:06:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77771, encodeId=780ee7771fb, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Apr 14 08:15:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77711, encodeId=71f1e771115, content=工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77710, encodeId=acb6e771087, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:15:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77580, encodeId=1477e7580e9, content=好想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Wed Apr 13 05:43:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77577, encodeId=2dafe757793, content=非常赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Apr 12 23:47:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77574, encodeId=4c3fe75743e, content=如此期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIuqOuvZLWMJ8yAVHKNPBSKWLKHx7ibIhutJv2OfnTK9MQH5jpicpw5EJTmD0M0q2wOG3CZO9wTxa9A/132, createdBy=75561684788, createdName=yilibaisha, createdTime=Tue Apr 12 23:26:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77572, encodeId=0e2de757204, content=期待好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3wX2G6elNRPKfNx9ZncyrF3PLdiaO0ua9zmSwUV0gyyNQhoG3ObEqbruynTicFKTDNAbYdlgjqS6UbT80ricnV8zgO/0, createdBy=47021668212, createdName=hbjxgrp1213, createdTime=Tue Apr 12 23:00:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2016-04-13 dylqjun

    工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=78626, encodeId=dfd4e8626e1, content=预祝成功!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Apr 15 21:55:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77953, encodeId=0247e7953c7, content=赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:07:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77952, encodeId=b95ae795270, content=期待进一步, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:06:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77771, encodeId=780ee7771fb, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Apr 14 08:15:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77711, encodeId=71f1e771115, content=工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77710, encodeId=acb6e771087, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:15:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77580, encodeId=1477e7580e9, content=好想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Wed Apr 13 05:43:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77577, encodeId=2dafe757793, content=非常赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Apr 12 23:47:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77574, encodeId=4c3fe75743e, content=如此期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIuqOuvZLWMJ8yAVHKNPBSKWLKHx7ibIhutJv2OfnTK9MQH5jpicpw5EJTmD0M0q2wOG3CZO9wTxa9A/132, createdBy=75561684788, createdName=yilibaisha, createdTime=Tue Apr 12 23:26:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77572, encodeId=0e2de757204, content=期待好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3wX2G6elNRPKfNx9ZncyrF3PLdiaO0ua9zmSwUV0gyyNQhoG3ObEqbruynTicFKTDNAbYdlgjqS6UbT80ricnV8zgO/0, createdBy=47021668212, createdName=hbjxgrp1213, createdTime=Tue Apr 12 23:00:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2016-04-13 dylqjun

    期待

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=78626, encodeId=dfd4e8626e1, content=预祝成功!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Apr 15 21:55:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77953, encodeId=0247e7953c7, content=赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:07:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77952, encodeId=b95ae795270, content=期待进一步, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:06:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77771, encodeId=780ee7771fb, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Apr 14 08:15:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77711, encodeId=71f1e771115, content=工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77710, encodeId=acb6e771087, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:15:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77580, encodeId=1477e7580e9, content=好想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Wed Apr 13 05:43:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77577, encodeId=2dafe757793, content=非常赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Apr 12 23:47:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77574, encodeId=4c3fe75743e, content=如此期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIuqOuvZLWMJ8yAVHKNPBSKWLKHx7ibIhutJv2OfnTK9MQH5jpicpw5EJTmD0M0q2wOG3CZO9wTxa9A/132, createdBy=75561684788, createdName=yilibaisha, createdTime=Tue Apr 12 23:26:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77572, encodeId=0e2de757204, content=期待好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3wX2G6elNRPKfNx9ZncyrF3PLdiaO0ua9zmSwUV0gyyNQhoG3ObEqbruynTicFKTDNAbYdlgjqS6UbT80ricnV8zgO/0, createdBy=47021668212, createdName=hbjxgrp1213, createdTime=Tue Apr 12 23:00:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2016-04-13 Dr.LV

    好想法

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=78626, encodeId=dfd4e8626e1, content=预祝成功!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Apr 15 21:55:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77953, encodeId=0247e7953c7, content=赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:07:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77952, encodeId=b95ae795270, content=期待进一步, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:06:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77771, encodeId=780ee7771fb, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Apr 14 08:15:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77711, encodeId=71f1e771115, content=工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77710, encodeId=acb6e771087, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:15:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77580, encodeId=1477e7580e9, content=好想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Wed Apr 13 05:43:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77577, encodeId=2dafe757793, content=非常赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Apr 12 23:47:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77574, encodeId=4c3fe75743e, content=如此期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIuqOuvZLWMJ8yAVHKNPBSKWLKHx7ibIhutJv2OfnTK9MQH5jpicpw5EJTmD0M0q2wOG3CZO9wTxa9A/132, createdBy=75561684788, createdName=yilibaisha, createdTime=Tue Apr 12 23:26:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77572, encodeId=0e2de757204, content=期待好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3wX2G6elNRPKfNx9ZncyrF3PLdiaO0ua9zmSwUV0gyyNQhoG3ObEqbruynTicFKTDNAbYdlgjqS6UbT80ricnV8zgO/0, createdBy=47021668212, createdName=hbjxgrp1213, createdTime=Tue Apr 12 23:00:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2016-04-12 lyh994

    非常赞\(≧▽≦)/

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=78626, encodeId=dfd4e8626e1, content=预祝成功!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Apr 15 21:55:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77953, encodeId=0247e7953c7, content=赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:07:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77952, encodeId=b95ae795270, content=期待进一步, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:06:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77771, encodeId=780ee7771fb, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Apr 14 08:15:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77711, encodeId=71f1e771115, content=工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77710, encodeId=acb6e771087, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:15:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77580, encodeId=1477e7580e9, content=好想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Wed Apr 13 05:43:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77577, encodeId=2dafe757793, content=非常赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Apr 12 23:47:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77574, encodeId=4c3fe75743e, content=如此期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIuqOuvZLWMJ8yAVHKNPBSKWLKHx7ibIhutJv2OfnTK9MQH5jpicpw5EJTmD0M0q2wOG3CZO9wTxa9A/132, createdBy=75561684788, createdName=yilibaisha, createdTime=Tue Apr 12 23:26:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77572, encodeId=0e2de757204, content=期待好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3wX2G6elNRPKfNx9ZncyrF3PLdiaO0ua9zmSwUV0gyyNQhoG3ObEqbruynTicFKTDNAbYdlgjqS6UbT80ricnV8zgO/0, createdBy=47021668212, createdName=hbjxgrp1213, createdTime=Tue Apr 12 23:00:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2016-04-12 yilibaisha

    如此期待

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=78626, encodeId=dfd4e8626e1, content=预祝成功!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Fri Apr 15 21:55:00 CST 2016, time=2016-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77953, encodeId=0247e7953c7, content=赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:07:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77952, encodeId=b95ae795270, content=期待进一步, beContent=null, objectType=article, channel=null, level=null, likeNumber=111, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 18:06:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77771, encodeId=780ee7771fb, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e0ee1691188, createdName=1de5ae28m43(暂无匿称), createdTime=Thu Apr 14 08:15:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77711, encodeId=71f1e771115, content=工作忙,外出进修不现实,支离破碎的参加学术会,必定不系统, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:16:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77710, encodeId=acb6e771087, content=期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1cf11319932, createdName=dylqjun, createdTime=Wed Apr 13 20:15:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77580, encodeId=1477e7580e9, content=好想法, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Wed Apr 13 05:43:00 CST 2016, time=2016-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77577, encodeId=2dafe757793, content=非常赞\(≧▽≦)/, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Apr 12 23:47:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77574, encodeId=4c3fe75743e, content=如此期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIuqOuvZLWMJ8yAVHKNPBSKWLKHx7ibIhutJv2OfnTK9MQH5jpicpw5EJTmD0M0q2wOG3CZO9wTxa9A/132, createdBy=75561684788, createdName=yilibaisha, createdTime=Tue Apr 12 23:26:00 CST 2016, time=2016-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77572, encodeId=0e2de757204, content=期待好久了, beContent=null, objectType=article, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3wX2G6elNRPKfNx9ZncyrF3PLdiaO0ua9zmSwUV0gyyNQhoG3ObEqbruynTicFKTDNAbYdlgjqS6UbT80ricnV8zgO/0, createdBy=47021668212, createdName=hbjxgrp1213, createdTime=Tue Apr 12 23:00:00 CST 2016, time=2016-04-12, status=1, ipAttribution=)]
    2016-04-12 hbjxgrp1213

    期待好久了

    0

相关资讯

梅斯医生,虚拟现实在线诊疗系统画面大曝光

梅斯医生,国内第一款虚拟现实在线诊疗系统,一款重新定义医学继续教育模式的产品,梅斯医生将于4月22日正式上线,届时也欢迎大家报名参加发布会。临床诊疗是医疗的核心,也是临床医生最核心的技能,需要通过长时间,多途径,大量的接触患者,才能不断提升。诊疗能力背后是不断更新的医学知识、临床医学经验的积累。梅斯医生的开发希望能加速临床医生职业的成长过程,进而改善医疗质量。哪怕将医生的职业进程加速一年或两年,也

梅斯医生---虚拟现实技术颠覆传统医学继续教育

“梅斯医生”,一款重新定义医学继续教育模式的产品,即将正式上线,也标志着医学继续教育行业面临新的变革。 医学知识更新迅速,临床对疾病诊疗的精准性要求日益提高,对于年轻医生成长形成巨大的挑战。临床医生往往整天面对海量的患者,但是罕见疾病,复杂和急重症患者往往都交由资深的临床主任级专家处理。这些棘手病患对临床医生的成长至关重要,而这种成长与学习具有高昂的时间成本。如何让年轻临床医生亲手诊疗大量的棘手

梅斯医生---国内**款虚拟现实在线诊疗系统,内测上线

“梅斯医生”,一款重新定义医学继续教育模式的产品,是国内首家把3D技术与医学教育相结合的一款虚拟仿真在线诊疗系统,这也标志着医学继续教育行业面临新的变革。 梅斯医生将于4月22日正式上线。(PS:凡是下载MedSci医学APP的小伙伴,均可报名参加内测,内测人数仅限额100名,审核通过并完成内测反馈用户将获得精装版线控小米耳机1副) “梅斯医生”关键词: 第一、增强实景,带来深入的沉浸

梅斯医生:4月22日正式上线,小M邀您参加发布会

4月22日产品发布会,我们不见不散!报名链接:

4月22日“梅斯医生”国内**款虚拟现实在线诊疗系统产品发布会,火热报名中

“梅斯医生”,一款重新定义医学继续教育模式的产品,即将正式上线,也标志着医学继续教育行业面临新的变革。梅斯医生将于4月22日正式上线届时将于上海举办“梅斯医生发布会”,在发布会现场,专门设置“梅斯医生”体验馆,用一个小小的眼镜,带你“上天入地”!点击链接,直接报名参加发布会,http://www.medsci.cn/z/msys/mt.html医学知识更新迅速,临床对疾病诊疗的精准性要求日益提高,

火遍全球的虚拟现实技术+医疗,真的可以实现

最近有媒体称,阿里巴巴宣布成立VR(虚拟现实)实验室,据悉,阿里VR实验室成立后的第一个项目就是“造物神”计划,目标是联合商家建立世界上最大的3D商品库,加速实现虚拟世界的购物体验。而就在4月1日下午,淘宝推出全新购物方式Buy+。Buy+使用VirtualReality(虚拟现实)技术,利用计算机图形系统和辅助传感器,生成可交互的三维购物环境,真实的实现各地商场随便逛,各类商品随便试的体验,不过